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Purpose: To report the findings of the clinical and molecular evaluation in a Greek family with fleck corneal dystrophy
(CFD).
Methods: A 58-year-old woman was seen on routine ophthalmic examination and diagnosed as having CFD. All available
family members were examined to evaluate the clinical findings and inheritance of the disease. Twenty members of the
family in five generations underwent slit-lamp examination. Eleven were females and nine males, aged from two years
to 85 years old. Blood samples were available from four patients with CFD and seven unaffected relatives, and the DNAs
were subjected to molecular screening of the phosphoinositide kinase, five finger-containing (PIKFYVE) gene by direct
sequencing or denaturing high performance liquid chromatography (DHPLC).
Results: The clinical evaluation revealed six family members (five females and one male) with CFD. In two CFD patients
early cataract formation was noticed. All patients affected with the corneal dystrophy were asymptomatic. The molecular
analyses demonstrated the existence of a novel c.3060–3063delCCTT (p.P968Vfs23) mutation in PIKFYVE in all CFD
patients tested but in none of the six unaffected family members. No molecular screening was performed in the seventh
unaffected member as the causative mutation was clearly transmitted from his affected wife to his affected son.
Conclusions: We report on the clinical and molecular findings of a five generation Greek family with CFD and we
conclude that the novel c.3060–3063delCCTT (p.P968Vfs23) mutation in PIKFYVE, which segregated with the disease,
was the causative mutation in this family.
Fleck corneal dystrophy (CFD, OMIM 121850) is a rare
autosomal dominant stromal dystrophy beginning early in life
and is characterized by flat, gray-white, tiny flecks scattered
throughout the stroma. The flecks have comma, oval, circular
or stellate shapes. Histologically only abnormal keratocytes
are involved, which contain excess glycosaminoglycan and
complex lipids. Typically, the stroma in between the flecks is
clear, and the endothelium, epithelium, Bowman layer, and
Descemet membrane are normal. The flecks in CFD may
appear as early as at two years of age or even at birth, and
generally  they  are  reported  not  to  progress  significantly
throughout life. Although CFD is thought to be rare, specific
incidence figures are difficult to obtain. François and Neetens
described the condition for the first time in 1957 [1]. Several
reports  have  proven  the  autosomal  dominant  pattern  of
inheritance of this corneal dystrophy [2-4]. CFD has been
linked  to  chromosome  2q35  [5]  due  to  mutations  in  the
phosphoinositide kinase, five finger-containing (PIKFYVE)
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gene,  also  known  as  PIP5K3  (phosphatidylinositol-3-
phosphate/phosphatidylinositol  5-kinase  type  III)  [4].
PIKFYVE belongs to a large family of lipid kinases that alter
the  phosphorylation  status  of  intracellular
phosphatidylinositol [6]. The content of phosphatidylinositol
3,5-bisphosphate (PtdIns(3,5)P2) in endosomal membranes
changes  dynamically  with  fission  and  fusion  events  that
generate or absorb intracellular transport vesicles. PIKFYVE
is the PtdIns(3,5)P2-producing component of a trimolecular
complex  that  tightly  regulates  the  level  of  PtdIns(3,5)P2.
Other components of this complex are the PIKFYVE activator
VAC14  and  the  PtdIns(3,5)P2  phosphatase  FIG4  [7].  In
addition to its phosphoinositide 5-kinase activity, PIKFYVE
also has protein kinase activity [8]. PIKFYVE contains 41
coding exons spanning more than 89 kb, and encodes a 2,089-
amino acid protein [4].
In this study we present on the clinical and molecular
genetic  examinations  performed  on  CFD  patients  and
unaffected  relatives  in  a  five  generation  family  of  Greek
origin.
METHODS
Family participants: A 58-year-old woman (Figure 1, II:6)
was seen on routine ophthalmic examination and diagnosed
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2776as having CFD. All available family members were examined
to  evaluate  clinical  findings  and  the  genetic  inheritance
pattern of the disease. Twenty members of the family in five
generations (Figure 1, Ι:1, II:1, II:2, ΙΙ:6, II:7, II:8, II:9, III:2,
III:9, III:10, III:11, III:12, III:13, III:14, III:16, IV:1, IV:7, IV:
9, IV:10, V:1) underwent slit-lamp examination. Eleven were
females (Figure 1, Ι:1, II:2, ΙΙ:6, II:8, III:2, III:10, III:11, III:
14, IV:1, IV:9, V:1) and nine males (Figure 1, II:1, II:7, II:9,
III:9, III:12, III:13, III:16, IV:7, IV:10), aged from two years
to 85 years old.
Sequencing  and  DHPLC  analyses:  Blood  samples  were
available from four patients with CFD (Figure 1, II:2, II:6, III:
11, and III:13) and seven unaffected relatives (Figure 1, II:1,
II:7, II:9, III:2, III:10, III:12, and III:14). DNA was isolated
from  EDTA-anticoagulated  blood  samples  by  a  standard
Figure 2. Photo of CFD in case II:6.
salting out procedure [9]. Coding exons and adjacent intronic
sequences of PIKFYVE were amplified from genomic DNA
of the proband (Figure 1, II:6) by use of the primers shown in
Appendix 1. PCR amplification of each of the 41 exons was
performed in 20 μl reactions involving 2.5 U of AmpliTaq
Gold (Applied Biosystems, Foster City, CA), 2 μl of 10×
AmpliTaq Gold Buffer, 1.9 mM MgCl2, 0.25 mM dNTPs,
0.25 mM of primers, and 40 mg of genomic DNA. PCR
cycling conditions consisted of an initial 10 min denaturation
step at 95 °C for 5 min; 32 cycles at 94 °C for 40 s, 55 °C for
30 s (61 °C for exon 19b), and 72 °C for 40 s; and a final
elongation step at 72 °C for 7 min. The PCR templates were
sequenced using ABI Dye Terminator (Applied Biosystems,
Foster City, CA), version 1, in a final reaction volume of
Figure 3. Cataract formation in case II:6.
Figure 1. Pedigree of the family with CFD.
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277710 μl. Products of the sequencing reactions were purified
using  the  Performa  DTR  gel-filtration  system  (Edge
BioSystems, Gaithersburg, MD) and were run on a 3100 ABI
genetic  analyzer  (Applied  Biosystems).  Sequences  were
aligned  with  the  reference  genomic  sequence  (GenBank
NM_015040) using the Seqman program of the DNASTAR
package  (DNASTAR,  Inc.,  Madison,  WI)  or  Chromas,
version 2.23 (Technelysium Pty Ltd, Brisbane, Australia).
The primer sets and annealing temperatures used are shown
in  Appendix  1.  Denaturing  high  performance  liquid
chromatography (DHPLC) was used to test co-segregation by
verifying the results of direct sequencing of the proband to the
other affected patients (Figure 1, II:2, III:11, and III:13). PCR
products were screened on a WAVE system (Transgenomics,
UK) at a temperature of 60.1 °C and starting at 58.5% B buffer.
Figure 4. Photo of CFD in case III:11.
Figure 5. Photo of CFD in case IV:9.
Written  informed  consent  was  obtained  from  all
participants. The clinical and molecular examinations were
in accordance with the Helsinki Declaration.
RESULTS
Slit-lamp examination revealed six members of the family
affected by CFD (Figure 1, I:1, II:2, II:6, III:11, III:13, and
IV:9).  In  two  CFD  patients  early  cataract  formation  was
noticed (Figure 1, II:2 66 years old, and II:6 58 years old). All
patients  affected  by  the  dystrophy  were  asymptomatic.
Inheritance of the condition in the family was compatible with
autosomal dominant inheritance. The clinical signs of patients
II:6, III:11, and IV:9 are presented in Figure 2 and Figure 3
(II:6), Figure 4 (III:11), and Figure 5 (IV:9).
Direct  sequencing  of  the  proband  (II:6)  revealed  the
existence  of  a  novel  heterozygous  c.3060–3063delCCTT
(p.P968Vfs23) mutation which is a 4-bp deletion in exon 20
of PIKFYVE (Figure 6). Co-segregation of the mutation tested
by DHPLC using the WAVE technology showed that the c.
3060–3063delCCTT (p.P968Vfs23) mutation was present in
all family members who were found to exhibit clinical signs
of CFD (Figure 1, II:2, III:11, III:13). WAVE results are
presented in Figure 7. Normal sequences were detected in
unaffected family members II:1, II:9, III:2, III:10, III:12, and
III:14 (Figure 1). No molecular screening was performed in
the  seventh  unaffected  member  (Figure  1,  II:7)  as  the
causative mutation was clearly transmitted from his affected
wife (Figure 1, II:6) to his affected son (Figure 1, III:13).
However, an abnormal sequence was detected by WAVE in
the unaffected member II:9 (Figure 7), which subsequently
revealed the existence of the non-pathogenic heterozygous
rs2363468 (T>C) single nucleotide polymorphism (SNP) by
direct sequencing. The c.3060–3063delCCTT (p.P968Vfs23)
Figure 6. Partial sequence chromatograms of the PIKFYVE gene
presenting  the  c.3060–3063delCCTT  mutation  in  heterozygosity
(upper panel), and a normal sequence (lower panel).
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2778mutation was not observed in 96 control individuals or in more
than  25  patients  with  CFD  previously  analyzed  in  our
laboratory.
DISCUSSION
Mutations in PIKFYVE have been implicated as the major
cause  of  CFD,  an  autosomal  dominant  human  disease
characterized  by  the  presence  of  numerous  white  flecks
scattered in all layers of the stroma [4]. PIKFYVE is a protein
important  for  post-Golgi  vesicle  processing.  Mammalian
PIKFYVE is a member of an evolutionarily ancient gene
family of PtdIns(3,5)P2-synthesizing enzymes that are large
proteins, represented by a single-copy gene in most, if not all,
species  with  sequenced  genomes,  including  the  zebrafish
[10,11]. Most of the reported mutations are of nonsense and
frameshift type and occur in and around the Cpn60_TCP1
domain,  predicting  termination  of  the  peptide  before  the
catalytic  domain.  Although  the  activity  of  the  PIKFYVE
protein or the PtdIns(3,5P)2 levels have not been determined
under these conditions, it is expected that the mutations will
result in a loss of PIKFYVE function. Given the lethality of
the  PIKfyve  null  mutations  in  model  organisms  [10],  the
asymptomatic  condition  of  the  CFD  patients  is  quite
surprising  but  could  be  attributed  to  the  presence  of  one
normal allele. Histological findings in CFD indicating that the
corneal flecks are swollen keratocytes containing membrane-
limited  empty  vacuoles  [12],  are  consistent  with  the
phenotypic  changes  seen  under  perturbed  PIKfyve
functionality [10].
In this study we reported our findings on the clinical
evaluation and the molecular genetic examination of a family
presenting CFD. To our knowledge, this is the first reported
family of Greek origin. The pedigree (Figure 1) consisted of
a total of 40 individuals in five generations, among which 20
were subjected to clinical evaluation, whereas 20 were not.
Among the 20 examined, six were found to be affected by
CFD (Figure 1, I:1, II:2, II:6, III:11, III:13, and IV:9), and 14
were not affected (Figure 1, II:1, II:7, II:8, II:9, III:2, III:9, III:
10, III:12, III:14, III:16, IV:1, IV:7, IV:10, V:1). Early cataract
was noticed in two CFD patients (Figure 1, II:2 and II:6). Four
individuals are deceased, including one affected (Figure 1, I:
1) and three not examined persons (Figure 1, I:2, II:5, III:17).
Mutational  screening  of  the  PIKFYVE  gene  by  direct
sequencing  in  the  proband  (Figure  1,  II:6)  revealed  the
existence  of  the  novel  mutation  c.3060–3063delCCTT  in
heterozygosity  (Figure  6).  This  4-bp  deletion  was  further
found  to  be  the  cause  of  a  frameshift  leading  to  the
p.P968Vfs23 alteration on the protein level. The mutation was
confirmed in all affected patients from which bloods were
drawn (Figure 1, II:2, III:11, III:13) by DHPLC analysis using
the WAVE technology. We conclude that the novel c.3060–
3063delCCTT (p.P968Vfs23) mutation in PIKFYVE, which
segregated with the disease, was the causative mutation in this
family.
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